Product
Vehicle Foam
2 clinical trials
2 indications
Indication
Seborrheic DermatitisIndication
ScabiesClinical trial
A Phase 3, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-154 Foam 0.3% Administered QD in Subjects With Seborrheic DermatitisStatus: Completed, Estimated PCD: 2022-04-06
Clinical trial
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison Study of the Safety and Efficacy of Permethrin Foam, 5% Versus Permethrin Foam, 4% Versus Vehicle in Subjects With Sarcoptes ScabieiStatus: Completed, Estimated PCD: 2014-12-01